Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review
Background: The Ebola virus has been responsible for numerous outbreaks since the 1970s, with the most recent outbreak taking place between 2014 and 2016 and causing an international public health emergency. Ebola virus disease (EVD) has a high mortality rate and no approved targeted treatment exist...
Saved in:
Main Authors: | Hussein Sweiti, MD, MSc, FACS (Author), Obinna Ekwunife, MSc, PhD (Author), Thomas Jaschinski, MHE (Author), Stefan K. Lhachimi, MPP, MSc, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage
by: Obinna I. Ekwunife, et al.
Published: (2017) -
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
by: Daouda Sissoko, MD, et al.
Published: (2017) -
Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
by: Dongrong Yi, et al.
Published: (2022) -
Ebola Survivor Corps: employing Ebola survivors as health educators and advocates in communities affected by Ebola in northern Sierra Leone
by: Nell Bond, PhD, et al.
Published: (2019) -
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019)